Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8e071d18fea054bf8d1420d483e78ed1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d1297bfc2e97de5f6be76176d577e937 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_07ead9e434b320281bfaa3060f405ebb http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7f9555b031d58564354b780c9c454982 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_01a96e8bbea00eeaa0b50c2a0c000dba |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-602 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-604 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-603 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-606 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2510-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-10343 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-86 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0696 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-861 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-074 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-10 |
filingDate |
2009-09-02^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6a06e198f5e225071756597dd7e32433 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d12429861357d1afe92019b6aa286461 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3abbbc3a6b0a7b35ce938c74cbcd5cba |
publicationDate |
2010-03-11^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2010028019-A2 |
titleOfInvention |
Direct reprogramming of somatic cells using non-integrating vectors |
abstract |
Provided herein are methods for producing induced pluripotent stem cells with the use of a non-integrating vector. Reprogramming of cells using a non-integrating vector (e.g., adenoviral vector) permits the generation of induced pluripotent stem cells that do not contain leftover viral genes that can be reactivated in the cell. This type of transient reprogramming is further contemplated for production of induced pluripotent stem cells for delivery to an individual. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9175268-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9499786-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9644184-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2011522540-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10106772-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9862930-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10370646-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9228204-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9328332-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10793833-B2 |
priorityDate |
2008-09-03^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |